PhD defenses 2010-2018

2018:

  • C.C.S. Tseng (May 24, 2018). Towards advanced therapy guidance in the failing heart.
  • J.J. de Haan (February 22, 2018). Inflammation in adverse cardiac remodeling – Is there impact to gain? [Abstract]
  • W.M. van Everdingen (February 15, 2018). Strategies to Improve Cardiac Resynchronization Therapy. [Abstract]
  • E.L. Kessler (January 25, 2018). Myocardial remodeling during pathophysiology: Relevance for cardiac dysfunction. [Abstract]
  • N.D. Paauw (January 23, 2018). Life after placental dysfunction: the mother’s renal function and her child’s health. [Abstract]
  • A. Gohar (January 16, 2018). Cardiovascular disease in men and women: different but equal. [Abstract]

 

2017:

  • D. Kofink (December 1, 2017). Use of novel biomarkers to explore cardiovascular risk and drug effects. [Abstract]
  • A. Bossu (November 30, 2017). Innovative antiarrhythmic strategies in the chronic atrioventricular block dog.
  • A.C. Abrahams (November 23, 2017). Novel insights in fibrotic and infectious complications of peritoneal dialysis.
  • G.A. Zoet (November 14. 2017). Beyond pregnancy: development of cardiovascular disease after preeclampsia. [Abstract]
  • R.F. Spee (November 1, 2017). Exercise hemodynamics in chronic heart failure: physiological and clinical aspects. [Abstract]
  • Y. Ji (October 31, 2017). Evaluating inward rectifier current inhibition for treatment of atrial fibrillation.
  • I.E.M. Bank (October 12, 2017). Ischaemic heart disease: early recognition and risk disparities. [Abstract]
  • M.M.P. Driessen (September 28, 2017). The pressure-loaded right ventricle. [Abstract]
  • I.A.H. ter Horst (September 21, 2017). Cardiac Remodelling Following Dyssynchrony and Cardiac Resynchronization Therapy.
  • G.H.J.M. Ellenbroek (September 14, 2017). Targeting inflammation in atherosclerosis and myocardial infarction. [Abstract]
  • Haelst, S.T.W. (September 7, 2017). Predictors and novel treatments for restenosis in peripheral arterial disease. [Abstract]
  • Jansen, R. (June 20, 2017). Optimized strategies for the management of mitral valve disease. [Abstract]
  • Visser, M. (June 15, 2017). Idiopathic ventricular fibrillation: the importance of long-term follow-up.
  • Teunissen, C. (June 15, 2017). Contemporary challenges in radiofrequency catheter ablation of atrial fibrillation. [Abstract]
  • Zwetsloot, P.P.M. (April 13, 2017). Bridging gaps in cardiac repair; looking back to think ahead. [Abstract]
  • Wijers, S.C. (April 11, 2017). The potential role of electrocardiographic markers to tune cardiac device therapy. [Abstract]
  • Deddens, J.C. (March 30, 2017). Translational cardiology for ischemic heart disease.
  • Haitjema, S. (March 23, 2017). Sex matters to the arteries – studies into the (epi)genetic background and clinical outcome of atherosclerotic disease in women and men. [Abstract]
  • Beeftink, M. (February 22, 2017). Challenges in the management of hypertension and heart failure. [Abstract]
  • Osch, D. (February 21, 2017).  Inflammation related cardiac complications of heart surgery. [Abstract]


2016:

  • Van der Laan, S. (October 12, 2016). The genetics of carotid atherosclerosis. Associations with clinical outcome and histological plaque characteristics. [Abstract]
  • Van den Akker, F. (September 15, 2016). Stem cell therapy against cardiac inflammation. [Abstract]
  • Hashemi, S.M. (July 5, 2016). Predicting inhibitor development in severe hemophilia: the future is not set.
  • Dunnink, A. (June 30, 2016). The relation between Bradycardic Dyssynchroneous Ventricular Activation, Remodeling and Arrhythmogenesis. [Abstract]
  • De Maat, S. (June 9, 2016).  Natural Pathways for Factor XII Activation:  implications for hereditary angioedema. [Abstract]
  • Siemelink, M.A. (May 12, 2016). Exploring the complex biology of the carotid atherosclerotic plaque. [Abstract]
  • Daan, N.M.P. (April 28, 2016). Women’s health implications of ovulatory dysfunction. [Abstract]
  • Mastenbroek, M.H. (April 7, 2016). How to improve implantable cardioverter defibrillator therapy: Focus on patient-reported outcomes and enhanced programming.
  • Leenders, G.E.H. (March 17, 2016). Physiologic insights and clinical consequences of mechanical discoordination in left bundle branch block. [Abstract]
  • Van ‘t Sant, J. (February 4, 2016). Clinical aspects of cardiac resynchronization therapy. [Abstract]
  • Te Riele, A.S.J.M. (January 15, 2016). Towards improvement of early detection and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy.


2015: 

  • Gijsberts, C.M. (December 17, 2015). Coronary artery disease: ethnicity, sex and risk prediction.
  • Nijhoff, F. (December 3, 2015). Evolving concepts in transcatheter aortic valve implantation. [Abstract]
  • Stecher, D. (October 30, 2015). Laser-assisted coronary anastomotic connector. A journey into the development and preclinical evaluation. [Abstract]
  • Gho, J.M.I.H. (October 29, 2015). Opportunities in the failing heart. [Abstract]
  • Van Hout, G.P.J. (October 22, 2015). Experimental myocardial infarction: the quest for novel therapeutics. [Abstract]
  • Fontes, M. (September 3, 2015). Conductional remodeling and arrhythmias in the diseased heart. [Abstract]
  • De Jong, S. (August 27, 2015). Improved detection of cardiac fibrosis. Biomarkers and novel imaging techniques. [Abstract]
  • Jansen of Lorkeers, S.J. (August 25, 2015). Pre-clinical research in cardiac repair. [Abstract]
  • Van der Meer, M.G. (June 17, 2015). Gender differences in diagnosis & prognosis of coronary artery disease. [Abstract]
  • De Hoog, V.C. (May 28, 2015).  Early assessment and treatment of myocardial infarction. [Abstract]
  • Huibers, M.M.H. (April 13, 2015). Cardiac allograft vasculopathy. Molecular pathology of the transplanted heart. [Abstract]
  • Verloop, W.L. (April 2, 2015). The dreams of renal denervation: a translational approach. [Abstract]


2014: 

  • Samim, M. (December 18, 2014). Transcatheter aortic valve replacement: optimisation of the technique and future challenges.
  • Blank, A.C. (December 8, 2014). Congenital complete atrioventricular block; clinical and experimental studies.
  • Vrijenhoek, J.E.P. (December 4, 2014). The atherosclerotic plaque and cardiovascular disease progression in men and women. [Abstract]
  • Groeneweg, J.A. (November 6, 2014). Arrhythmogenic cardiomyopathy: impact of genotype, clinical course, and long-term outcome. [Abstract]
  • Dewilde, W.J.M. (September 22, 2014). Optimal antiplatelet and anticoagulant therapy in patients with oral anticoagulation in coronary stenting. [Abstract]
  • Feyen, D.A.M. (September 16, 2014). Strategies to improve cardiac cell therapy. [Abstract]
  • Siddiqi, S. (June 25, 2014). The orchestra of myocardial regeneration. [Abstract]
  • Neven, K.G.E.J. (June 24, 2014). Novel energy modalities for catheter ablation of cardiac arrhythmias. Pitfalls and possibilities of potent power sources. [Abstract]
  • Tragante do Ó, V. (June 24, 2014). Application of bioinformatics in cardiovascular genomics. [Abstract]
  • Van den Borne, P. (June 24, 2014). Changing blood flow in peripheral artery disease. [Abstract]
  • Tanis, W. (June 20, 2014). Novel imaging strategies for the detection of prosthetic heart valve obstruction and endocarditis. [Abstract]
  • Kranendonk, M.G.E. (June 19, 2014). Adipose tissue dysfunction and cardiometabolic risk; ex vitro, in vivo and clinical studies. [Abstract]
  • Du, X. (June 16, 2014). The expanding horizons in thrombosis and hemostasis. [Abstract]
  • Stams, T.R.G. (June 16, 2014). Torsade de Pointes: Risk prediction and role of ventricular activation. [Abstract]
  • Rutten, B. (June 6, 2014). Platelet adherence during inflammatory diseases. Quantity matters! [Abstract]
  • Scholtes, V.P.W. (May 27, 2014). Local plaque characteristics and circulating cells in atherosclerosis. The Athero-Express biobank. [Abstract]
  • Buikema, J.W. (May 22, 2014). Molecular control of ventricular growth and cardiomyocyte proliferation. [Abstract]
  • Van Slochteren, F. (April 23, 2014). Technical solutions to improve cardiac regenerative therapy. [Abstract]
  • Koudstaal, S. (March 21, 2014). Protection and repair of the ischemic heart. [Abstract]
  • Soni, S. (February 20, 2014). Maladaptive kinase signaling and protein-protein Interactions in cardiac diseases. [Abstract]
  • Warnier, M.J. (February 10, 2014). Disease and drug-induced arrhythmias : the example of obstructive pulmonary disease. [Abstract]
  • Varkevisser, R. (February 6, 2014). Is it safe? Adverse drug effects and cardiac arrhythmias. [Abstract]
  • Hyseni, A. (January 27, 2014). Nanobody technology in thrombosis and haemostasis research. [Abstract]


2013: 

  • Van Bladel, E.R. (December 6, 2013). Platelet function in bleeding disorders. [Abstract]
  • Lok, S.I. (December 5, 2013). Myocardial changes in patients with end-stage heart failure during continuous flow left ventricular assist device support. [Abstract]
  • Elsenberg, E.H.A.M. (November 8, 2013). Toll-like receptor response and circulating cells in cardiovascular disease. [Abstract]
  • Willems, S. (October 31, 2013). Target Identification in Neovascularization. [Abstract]
  • Tersteeg, C. (June 27, 2013). Platelets in Atherothrombosis. [Abstract]
  • Gitz, E. (June 13, 2013). Glycoprotein Ibα clustering in platelet storage and function. [Abstract]
  • Van Holten, T. (June 11, 2013). On platelet biology and cardiovascular disease. [Abstract]
  • Bourgonje, V. (May 14, 2013). The multifunctional role of calcium in the heart: a tempting target. [Abstract]
  • Vrijsen, K.R. (April 23, 2013). Exosomes in cardiac injury and repair. [Abstract]
  • Van Koppen, A.N. (March 19, 2013). Cell-based therapies for chronic kidney disease. [Abstract]
  • Tuinenburg, A. (March 11, 2013). Congenital clotting factor deficiency and cardiovascular disease: protected by nature? [Abstract]
  • Martina, J. (February 22, 2013). Continuous-Flow Left Ventricular Assist Devices: Clinical and Technical Aspects. [Abstract]
  • Belkacemi, A. (February 5, 2013). A new interventional strategy in complex coronary artery disease: drug-eluting balloons; clinical results and OCT analysis. [Abstract]
  • Koole, D. (January 26, 2013). The abdominal aortic aneurism: clinical outcomes in EVAR and longitudinal biobank studies. [Abstract]

 

2012: 

  • Van der Spoel, T.I.G. (December 18, 2012). Optimization of delivery strategies for cardiac cell therapy in ischemic heart disease. [Abstract]
  • Oerlemans, M.I.F.J. (December 6, 2012). Myocardial infarction: early diagnosis and cardioprotective strategies. [Abstract]
  • Van Mil, A. (November 29, 2012). MicroRNAs: novel targets for cardiac regenerative medicine. [Abstract]
  • Emans, M.E. (November 26, 2012). Red cell dynamics and haemodynamics in cardiorenal failure. [Abstract]
  • Agour, E.N.E. (October 31, 2012). Proton and sodium MRI assessment of myocardial viability. [Abstract]
  • Noorman, M. (October 23, 2012). Arrhythmogenic remodeling of the intercalated disk. [Abstract]
  • De Heer, L.M. (October 16, 2012. Non-invasive imaging of the aortic root: towards optimal evaluation and sizing of stented (tissue engineered) heart valves. [Abstract]
  • Verhagen, S. (September 11, 2012). Local and systemic effects of visceral and perivascular adipose tissue. [Abstract]
  • Van Lammeren, G.W. (June 14, 2012). The atherosclerotic plaque: risk factors and cardiovascular outcome after carotid endarterectomy. [Abstract]
  • Haverslag, R.T. (May 10, 2012). Leukocytes and Perfusion Recovery after Arterial Occlusion. [Abstract]
  • Bovens, S.M. (February 3, 2012). Cardiovascular applications of magnetic resonance imaging. [Abstract]
  • Hof, I.E. (January 19, 2012). Impact of catheter ablation of atrial fibrillation on the left atrium. [Abstract]


2011: 

  • Jonsson, M.K.B. (December 12, 2011). Applicability of human stem cell-derived cardiomyocytes for safety pharmacology. [Abstract]
  • Hurks, R. (December 8, 2011). Discrepancies in abdominal aortic aneurysm expressions and repair. [Abstract]
  • Riem Vis, P.W. (November 29, 2011). Towards new therapies for calcific aortic valve disease. [Abstract]
  • Derksen, W.J.M. (November 24, 2011). The clinical value of histological femoral artery plaque analysis. [Abstract]
  • Chaldoupi, M. (November 10, 2011). Electrophysiological and genetic insights into atrial fibrillation. [Abstract]
  • Jansen, J.A. (November 1, 2011). Abnormal conduction in the diseased heart – Enhanced fibrosis due to reduced gap junction and sodium channel expression. [Abstract]
  • Branden, B.J.L. van den (September 28, 2011). Innovation in intervention: New devices in interventional cardiology. [Abstract]
  • Nalos, L. (September 16, 2011). Probing cardiac repolarization reserve in drug safety assessment. [Abstract]
  • Arslan, F. (September 6, 2011). Enhancing cardiac repair: Targeting 1/R injury and adverse remodeling. [Abstract]
  • Liu, J. (August 25, 2011). Novel strategies for enhancing myocardial healing. [Abstract]
  • Groot, D. de (June 21, 2011). Inflammatory processes during arteriogenesis. The contribution of the innate immune system to collateral artery growth. [Abstract]
  • Oosterhoff, P. (May 19, 2011). The use of repolarization variability for arrhythmic risk monitoring. “The rocking of the boat.” [Abstract]
  • Putten, K. van der (May 18, 2011). Anemia and response to erythropoietin in the cardiorenal syndrome. [Abstract]
  • Oorschot, A.A.M. van (May 12, 2011). Progenitor cells from the heart: in vitro study of CMPC and EPDC behavior. [Abstract]
  • Cox, M.G.P.J. (April 7, 2011). Arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Activation delay, diagnosis and DNA.
  • Bongartz, L.G. (February 28, 2011). The severe cardiorenal syndrome. [Abstract]
  • Ionita, M.G. (February 17, 2011). Myeloid related protein-8/14, a marker of plaque and patient vulnerability. [Abstract]


 2010:

  • Boulaksil, M. (December 2, 2010). Arrhythmogenesis in the remodeled heart. The role of spatially dispersed Cx43 expression. [Abstract]
  • Boekhorst, B.C.M. te (May 11, 2010). MRI of Atherosclerosis. [Abstract]
  • Peeters, W. (April 15, 2010). Local atherosclerotic plaque biomarkers predict systemic clinical outcome. The translational Athero-Express biobank study. [Abstract]
  • Jie, K.E. (April 8, 2010). Circulating cells in heart and renal failure. [Abstract]
  • Luermans, J.G.L.M. (February 2, 2010). Paradoxical embolism, migraine and cardiac shunt closure. [Abstract]
  • Cate, T.J.F. ten (February 2, 2010). Myocardial perfusion studies in abnormal ventricular activation. [Abstract]